March 4, 2020 / 8:20 AM / a month ago

Takeda Pharmaceutical says it is developing coronavirus drug

TOKYO, March 4 (Reuters) - Takeda Pharmaceutical Co Ltd is developing a drug to treat high-risk individuals infected with coronavirus, it said on Wednesday.

The Japanese company said in a statement it is also studying whether its currently marketed and pipeline products may be effective treatments for infected patients.

“As a company dedicated to the health and well-being of people around the world, we will do all that we can to address the novel coronavirus threat,” Dr. Rajeev Venkayya, president of Takeda’s vaccine business, said in a statement.

Source text: (Reporting by Chris Gallagher; Editing by Jan Harvey)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below